Key Insights

Highlights

Success Rate

75% trial completion

Treatment Research

12 treatments under study, led by Glucagon For Injection Fresenius Kabi Usa

Research Leaders

9 sponsors active, led by Joslin Diabetes Center

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

75.0%

-11.6% vs benchmark

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (3)
Phase 4 (4)

Trial Status

Completed3
Recruiting1
Terminated1
Active Not Recruiting1
Unknown1

Trial Success Rate

75.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Glucagon For Injection Fresenius Kabi Usa2
  • Dexcom Cgm Unmasked1
  • Free Style Libre Pro Iq1
  • Use Of Continuous Glucose Monitoring1
  • Dexcom Cgm Masked1

Active Sponsors

  • Joslin Diabetes Center3
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
  • University of Alabama at Birmingham2
  • Barts & The London NHS Trust1
  • University of Virginia1

Top Investigators

Related Conditions

  • Hypoglycemia3
  • Bariatric Surgery2
  • Insulin Hypoglycemia1
  • Insulinoma1
  • Hypoglycemia Nondiabetic1

Activity Timeline